Skip to main content

Research Repository

Advanced Search

ROTEM thromboelastometry identifies blood product requirements during major obstetric haemorrhage.

Bolton, S; Harkness, Mairi; Thomson, S


S Bolton

Mairi Harkness

S Thomson


Introduction: major obstetric haemorrhage (MOH) is a
significant cause of maternal morbidity and mortality. Despite a lack of published evidence, thromboelastometry has been recommended for monitoring coagulation in obstetric patientswith MOH.
Methods: all patients with MOH requiring standard laboratory tests (SLT) for suspected coagulopathy were included and a paired ROTEM sample was taken. Indications for blood product transfusion and antifibrinolytic agents were determined by reference to the British Committee for Standards in Haematology and the ROTEM Expert Meeting Working Group algorithm. The sensitivity and specificity of the ROTEM algorithm for the requirement for FFP or platelet transfusion was calculated. Spearman's rank correlation coefficient and ROC curve analysis were applied to identify the ROTEM variables that most accurately guided therapy.
Results: 66 women met inclusion criteria, all with a blood loss >1.5 litres. 93 paired blood samples were analysed by SLT and ROTEM thromboelastometry. 21 pairs of blood samples from nine patients demonstrated coagulopathy requiring treatment. The ROTEM algorithm demonstrated excellent sensitivity (0.88) and specificity (0.96) for the presence of coagulopathy requiring treatment. Sensitivity and specificity for FFP transfusion were 0.76 and 0.96 respectively but for platelet transfusion sensitivity was poor (0.37) with a specificity of 0.97. Correlation between
FIBTEM MCF and fibrinogen levels was strongest (r=0.79, 95% CI 0.65 -0.88, P

Conference Name Obstetric Anaesthetists Association Annual Meeting
Start Date May 26, 2011
End Date May 27, 2011
Acceptance Date May 26, 2011
Publication Date Apr 28, 2011
Deposit Date Nov 13, 2015
Peer Reviewed Peer Reviewed
Pages S22
Keywords Blood; obstetrics;
Public URL